Activity Overview
RISE Performance Improvement is a three-stage performance improvement activity by which evidence-based performance measures and quality improvement interventions / changes are used to help providers identify patient care areas for improvement and positively change their performance.
Current RISE registry users will be able to assess their current quality measure performance in their 2026 RISE dashboard, select measures in which they would like to improve performance, implement changes within their practice for90 consecutive days to improve measure performance, and re-assess measure performance to see if and how their performance changed.
Target Audience
Rheumatologists and primary care providers; professionals interested or engaged in rheumatology research.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Assess their performance on quality measures and identify which measures need performance improvement
- Identify and implement change(s) in their practice to improve their quality measure performance
- Assess their quality measure performance after implementing the change(s) and summarize the outcome that resulted from implementing the change(s)
Price
Registration is complimentary.
CE & MOC Information
Credit must be claimed by December 31, 2026, at 11:59 PM ET.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.
After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you claimed credit. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.
The following credit types must be self-reported to the appropriate board: CME, AAPA, AANC, AWSB ACE, and APA. The certificate is a record of your activity completion.
All participating healthcare professionals should claim only the credit commensurate with the extent of their participation in this activity.
Available Credit
CME: 20.00 AMA PRA Category 1 Credit(s)™
ABIM MOC: 20.00 Medical Knowledge Points
Designation Statements
Joint Accreditation
In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider Number: 0003797
See the ACR's CE Mission Statement. For more information, download the AMA PRA Booklet.
AMA
The ACR designates this enduring activity for a maximum of 20.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Financial Relationship Disclosures
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Education (CE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence inAccredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CE activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
Advisor or review panel member
Consultant
Employee
Officer or Board Member
Grant/research support
Speaker/honoraria includes speaker’s bureau, symposia, and expert witness
Independent contractor
Executive role and/or ownership interest
Royalties and/or patent beneficiary
Intellectual property/patents
Stock options or bond holdings in a for-profit corporation or self-directed pension plan
Private investigator
Expert witness
Equity interest
Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. RISEPerformance Improvement 2025 Financial Relationship Disclosures
Acknowledgement of Commercial Support
No commercial support was provided for this activity.
See industry engagement opportunities and benefits of supporting the ACR.
Educational Activity Policies
See ACR educational activity policies, including the online enduring activity refund policy.
Use evidence-based performance measures and quality improvement interventions / changes to identify patient care areas for improvement.
Use evidence-based performance measures and quality improvement interventions / changes to identify patient care areas for improvement. Stage B is the Intervention Implementation.
Use evidence-based performance measures and quality improvement interventions / changes to identify patient care areas for improvement. Stage C is the Re-Assessment.
